Concepedia

P. Maslak

PM

Statistics

Publications

62

Citations

15K

H-Index

41

Active since

1993

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Kettering University

University of Pennsylvania

The University of Texas MD Anderson Cancer Center

P. Maslak is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1993–2021

62

Publications

62

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +17

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Isabelle Rivière, Xiuyan Wang et al. · Science Translational Medicine · 2014 · 2.5K citations · Full text

, , +17

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

, , +13

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

, , +11

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

Steven L. Soignet, P. Maslak, Zhugang Wang et al. · New England Journal of Medicine · 1998 · 1.2K citations

, , +9

1–5 of 62